Chao Xiao

<i>TP53</i> mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes

Chunkang Chang, Youshan Zhao, Feng Xu et al. · British Journal of Haematology · 2016 · 76 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Genetic Epidemiology +21

Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes

Lingyun Wu, Luxi Song, Lan Xu et al. · Tumor Biology · 2015 · 49 citations

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Feng Xu, Lingyun Wu, Chunkang Chang et al. · Nature Communications · 2015 · 41 citations · Full text

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Lingyun Wu, Wenhui Shi, Xiao Li et al. · Journal of Translational Medicine · 2016 · 22 citations · Full text

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Zheng Zhang, Qi He, Tao Ying et al. · PubMed · 2017 · 22 citations

Immunology, Tumor Cells, Immunotherapy +16